CRP and blood coagulation disease: Of interest, inflammatory biomarkers (CRP, ferritin, and procalcitonin), a lung injury biomarker (LDH), and a coagulopathy biomarker (D-dimer) were elevated in severe COVID-19 patients compared with mild-moderate COVID-19 (p < 0.05) and T2DM patients (p = 0.0001), as shown in Table 1.